Healthcare Services

A key trend shaping the Direct Coombs Test (DCT) Antibody Market involves the Advancing Transfusion Safety With Gel-Based Immunoassays

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Direct Coombs Test (DCT) Antibody Market By 2030 Starting From Its 2026 Size?

The direct coombs test (dct) antibody market has experienced substantial expansion in its size over recent years. Projections indicate it will expand from a value of $6.55 billion in 2025 to $7.3 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.5%. Historically, this growth can be ascribed to several factors, including an increase in biomedical research funding, the growing number of cancer research initiatives, the development of academic laboratory infrastructure, the broader application of antibodies in diagnostic procedures, and advancements in antibody engineering methodologies.

The direct coombs test (dct) antibody market is projected for significant expansion in the coming years. This market is anticipated to reach a valuation of $11.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. Factors driving this growth during the forecast period include the increasing scope of precision oncology research, a rising demand for advanced antibody formats, greater investments in biologics manufacturing, the expansion of personalized medicine uses, and improvements in antibody discovery platforms. Key trends observed within the forecast timeframe encompass the wider application of recombinant antibody technologies, a growing need for highly specific monoclonal antibodies, broader utilization of antibody applications in oncology studies, an increase in the uptake of bispecific antibody formats, and a heightened emphasis on scalable antibody manufacturing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30259&type=smp

What Primary Drivers Are Shaping The Development Of The Direct Coombs Test (DCT) Antibody Market?

The direct coombs test (DCT) antibody market is projected to grow due to the increasing demand for personalized medicine. Personalized medicine is a healthcare approach that customizes treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize results and improve care. The need for personalized medicine is rising, driven by advancements in genomic technologies that enable precise identification of genetic variations and tailored treatments for individuals. The direct coombs test (DCT) antibody supports personalized medicine by allowing accurate detection of antibodies or complement bound to red blood cells. It assists in identifying immune-mediated hemolytic conditions, which empowers clinicians to customize treatments according to a patient’s specific immune profile, thereby enhancing diagnostic accuracy and therapeutic outcomes. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, stated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the direct coombs test (DCT) antibody market.

Which Segment Categories Define The Direct Coombs Test (DCT) Antibody Market?

The direct coombs test (dct) antibody market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Bispecific Antibodies

2) By Source: Human, Mouse, Rabbit, Other Sources

3) By Application: Cancer Treatment, Autoimmune Diseases, Infectious Diseases, Transplant Rejection, Other Applications

4) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic And Research Institutes, Diagnostic Laboratories

Subsegments:

1) By Monoclonal Antibodies: Mouse Monoclonal Antibodies, Rabbit Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Chicken Polyclonal Antibodies, Donkey Polyclonal Antibodies

3) By Recombinant Antibodies: Mammalian Expression Recombinant Antibodies, Bacterial Expression Recombinant Antibodies, Yeast Expression Recombinant Antibodies, Insect Expression Recombinant Antibodies, Plant Expression Recombinant Antibodies

4) By Bispecific Antibodies: Immune Cell Engager Bispecific Antibodies, Dual Variable Domain Bispecific Antibodies, Cross Format Bispecific Antibodies, Knob And Hole Bispecific Antibodies, Fragment-Based Bispecific Antibodies

Which Upcoming Trends Are Expected To Influence The Direct Coombs Test (DCT) Antibody Market?

Leading companies in the direct coombs test (DCT) antibody market are prioritizing the development of advanced technological solutions, such as gel-based immunoassays, to ensure reliability, improve laboratory workflow, and maintain high standards for pre-transfusion testing. Gel-based immunoassays are laboratory tests where antibodies and antigens interact within a gel matrix, enabling the visual detection of reactions like agglutination. For example, in October 2025, QuidelOrtho Corporation, a US-based in-vitro diagnostics company, received Food and Drug Administration (FDA) clearance for its MTS DAT Card for gel-based direct antiglobulin testing on the ORTHO VISION platform. This product features a ready-to-use card containing anti-IgG and anti-C3d monospecific reagents embedded in the gel matrix of separate microtubes. This design permits clear, objective, and simultaneous differentiation between IgG and complement sensitization, thereby streamlining the investigation of immune-mediated hemolytic anemias and hemolytic disease of the fetus and newborn (HDFN). Its fundamental purpose is to detect immunoglobulin G or complement bound to red blood cells, which supports hemolysis investigation and enhances transfusion safety.

Who Are The Top Companies Competing In The Direct Coombs Test (DCT) Antibody Market?

Major companies operating in the direct coombs test (dct) antibody market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bio-Rad Laboratories Inc., Fortress Diagnostics Limited, Lab-Care Diagnostics (India) Pvt. Ltd., SIFIN Diagnostics GmbH, Hemo Bioscience Inc., Rapid Labs Ltd, AnaMol Laboratories Pvt. Ltd., Jiangyin Libo Biotechnology Co. Ltd., MicroSidd India Pvt. Ltd., Atlas Medical GmbH, Lorne Laboratories Ltd, Sanquin Reagents B.V., BAG Diagnostics GmbH, CE-Immundiagnostika GmbH, Biolab Diagnostics (India) Pvt. Ltd., Singapore Biosciences Pte. Ltd.

Read the full direct coombs test (dct) antibody market report here:

https://www.thebusinessresearchcompany.com/report/global-direct-coombs-test-dct-antibody-market-report

How Does The Direct Coombs Test (DCT) Antibody Market Perform Across Major Global Regions?

North America was the largest region in the direct coombs test (DCT) antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the direct coombs test (dct) antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Direct Coombs Test (DCT) Antibody Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30259&type=smp

Browse Through More Reports Similar to the Global Direct Coombs Test (DCT) Antibody Market 2026, By The Business Research Company

Antibody Discovery Global Market Report

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Research Antibodie And Reagent Global Market Report

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

C Reactive Protein Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795